Inventiva (IVA) Net Income (2019 - 2025)
Inventiva's (IVA) quarterly Net Income came in at $398.2 million in Q2 2025, up 854.15% year-on-year from $41.7 million in Q2 2024, and up 532417.83% quarter-over-quarter from -$74801.7 in Q4 2024.
Inventiva (IVA) Net Income (2019 - 2025) Analysis & Trends
Inventiva's Net Income history runs 7 years deep, the most recent figure standing at $398.2 million for Q2 2025.
- On a quarterly basis, Net Income rose 854.15% year-over-year to $398.2 million in Q2 2025; TTM through Dec 2025 was $345.3 million, a 750.07% increase from a year earlier, with the FY2025 full-year figure at -$411.9 million, down 55275.39% from the prior year.
- Net Income improved to $398.2 million in Q2 2025 per IVA's latest filing, from -$74801.7 in the prior quarter.
- Across five years, Net Income topped out at $398.2 million in Q2 2025 and bottomed at -$52.8 million in Q2 2024.
- The 5-year median for Net Income is -$13.9 million (2021), against an average of $23.0 million.
- Across the five-year window, Net Income sank 42808.89% in 2024 and jumped 854.15% in 2025, its largest moves.
- Year by year, Net Income stood at -$26.5 million in 2021, then retreated by 13.59% to -$30.1 million in 2022, then soared by 99.18% to -$245314.3 in 2023, then surged by 69.51% to -$74801.7 in 2024, then jumped by 532417.83% to $398.2 million in 2025.
- Per Business Quant, the three latest IVA Net Income figures stand at $398.2 million (Q2 2025), -$74801.7 (Q4 2024), and -$52.8 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 398.18 Mn |
| Dec 31, 2024 | -74,801.68 |
| Jun 30, 2024 | -52.80 Mn |
| Dec 31, 2023 | -245,314.30 |
| Jun 30, 2023 | -123,048.46 |
| Dec 31, 2022 | -30.06 Mn |
| Sep 22, 2022 | -30.73 Mn |
| Dec 31, 2021 | -26.47 Mn |
| Jun 30, 2021 | -17.22 Mn |
| Mar 31, 2021 | -10.66 Mn |
| Dec 31, 2020 | -18.67 Mn |
| Jun 30, 2020 | -9.76 Mn |
| Mar 31, 2020 | -7.50 Mn |
| Dec 31, 2019 | -22.74 Mn |